Background: Pharmacists in Portugal, New Zealand, the UK and USA are able to administer vaccines. Despite international trends, current jurisdictional regulations prevent Australian pharmacists from administering vaccines. Aim: To assess if there is a case for pharmacist administered vaccination (PAV) in Australia. Discussion: Studies and government data indicate suboptimal uptake of some vaccines in Australia. Over the past two decades, PAV services have been introduced successfully in some developed countries. Available literature revealed PAVs provided signifi cant benefi ts in these countries, such as increased vaccination uptake and subsequent decreased disease burden and associated cost benefi ts. PAVs are in line with Australian government policy and priorities. The pharmacy profession, guided by peak professional bodies, has demonstrated a willingness to embrace PAVs based on appropriate competencies and broadening health delivery options to the public. Conclusion: There is a case for PAV services in Australia. It is not possible to adopt an overseas model of PAVs in Australia without signifi cant modifi cation to its unique immunisation program, which incorporates a different funding and governance system.
|Number of pages||5|
|Journal||Journal of Pharmacy Practice and Research|
|Publication status||Published - 2013|
BUSHELL, M., Yee, K. C., & Ball, P. A. (2013). Case for pharmacist administered vaccinations in Australia. Journal of Pharmacy Practice and Research, 43(4), 292-296. . https://doi.org/10.1002/j.2055-2335.2013.tb00278.x